The Organizing Committee
- Gregory W. Randolph, MD, Harvard Medical School
- Bryan McIver, MD , Endocrine Experts LLC
- Ezra Cohen, MD, UC San Diego Health System
- Jeremy Freeman, MD, University of Toronto
- Bryan Haugen, MD, University of Colorado Health Sciences Centre
- Jatin P. Shah, MD, Memorial Sloan-Kettering Cancer Centre
- Ashok R. Shaha, MD, Memorial Sloan-Kettering Cancer Centre
- Steven I. Sherman, MD, UT MD Anderson Cancer Centre
- Ian J. Witterick, MD, University of Toronto
Gregory W. Randolph, MD
Gregory W. Randolph is an Associate Professor of Otolaryngology Head and Neck Surgery at Harvard Medical School and Surgeon at Massachusetts Eye & Ear Infirmary. He trained at Cornell and Harvard Medical Schools. He serves as Director of the General Otolaryngology Division since 1995 and founded and directs the Division of Thyroid and Parathyroid Surgery.
Dr. Randolph has a thyroid and parathyroid surgical practice seeing patients and operating at both Mass Eye and Ear Infirmary and Mass General Hospital. As a Head and Neck surgeon his surgical activity focuses exclusively on thyroid and parathyroid and related neck surgery.
Dr. Randolph has focused the bulk of his research on recurrent laryngeal nerve anatomy, preservation and monitoring during thyroid cancer surgery with focus on importance of laryngeal exam, recognition of lymph node metastasis and revision cancer surgery. He has lead thyroid surgical missions to thyroid surgical units in St. Petersburg, Russia, Guangzhou, China, and in the Chernobyl region of the Ukraine. He directs the Harvard Thyroid and Parathyroid Surgery Course for surgeons and has directed international surgical courses in Italy, Germany, Switzerland and Russia. He founded the first Otolaryngology based Thyroid and Parathyroid surgical fellowship in the U.S.
He has published an endocrine surgical text: “Surgery of the Thyroid and Parathyroid Glands” published by Saunders. This text has been nominated for a publishing industry award as a new and innovative surgical text and is being translated to Russian, Portuguese, Turkish and Chinese. He is the director of International Affairs for the American Academy of Otolaryngology Head and Neck Surgery and serves on their Board of Directors.
In both his book and Harvard Thyroid and Parathyroid course he has formed extensive collaborative ties between medical endocrinology, general/endocrine surgery and otolaryngology and was the first otolaryngologist to be admitted as a member of the general surgical AAES.
Bryan McIver, MD
Bryan McIver MB PhD is an Academic Endocrinologist, with a strong background in thyroid cancer and thyroid nodules, including both clinical and research interests in these areas.
A renowned clinician, respected educator and widely published researcher, Dr McIver was, until recently, a Consultant in Endocrinology at Mayo Clinic, Rochester, MN and Chair of the Mayo Clinic Thyroid Group. He will be commencing his new appointments, as Program Leader in Endocrine Malignancy, at the Moffitt Cancer Center and Professor of Endocrinology at the University of South Florida, in Tampa, FL, in May 2013.
Born and raised in Scotland, he received his medical degree from the University of Edinburgh and his PhD in Biophysics from the University of Vermont.
Following Residency training at the Royal Infirmary of Edinburgh he completed Fellowship in Endocrinology at Mayo Clinic and joined the Mayo staff in 1998. He participated in the ATA Guidelines writing committee for the 2006 and 2009 editions and is a charter member of the World Congress on Thyroid Cancer Organizing Committee.
Ezra Cohen, MD
Ezra Cohen, MD, is a board-certified oncologist and cancer researcher. He cares for patients with all types of head and neck cancers, including esophageal, thyroid and salivary gland cancers.
Dr. Cohen is also an internationally recognized expert on novel cancer therapies and heads the Solid Tumor Therapeutics program at Moores Cancer Center. Much of his work has focused on squamous cell carcinomas and cancers of the thyroid, salivary gland, and HPV-related oropharyngeal cancers. As a physician-scientist, he is especially interested in developing novel therapies and understanding mechanisms of sensitivity or resistance; cancer screening; and using medication and other agents to delay or prevent cancer (chemoprevention). He was recently appointed chair of the National Cancer Institute Head and Neck Cancer Steering Committee, which oversees NCI-funded clinical research in this disease.
Dr. Cohen is editor-in-chief of Oral Oncology, the most respected specialty journal in head and neck cancer. A frequent speaker at national and international meetings, he has authored more than 120 peer-reviewed papers and has been the principal investigator of multiple clinical trials of new drugs in all phases of development.
Prior to joining UC San Diego Health System in 2014, Dr. Cohen was co-director of the Head and Neck Cancer Program at the University of Chicago Comprehensive Cancer Center. A dedicated educator, Dr. Cohen also mentored and developed young faculty in his program.
Dr. Cohen earned his medical degree at University of Toronto. He completed residencies in family medicine at the University of Toronto and in internal medicine at Albert Einstein College of Medicine. He completed a hematology/oncology fellowship at the University of Chicago, where he was named chief fellow.
Jeremy Freeman, MD
Dr. Jeremy Freeman was born in Hamilton, Ontario and grew up in Toronto. He attended medical school at the University of Toronto, graduating with highest honours. He completed his otolaryngology residency at the University of Toronto.
After receiving his Fellowship from the Royal College of Surgeons of Canada in 1978, he spent two further years of advanced training, one as a Gordon Richards Fellow at the Princess Margaret Hospital in Toronto in Radiation and Medical Oncology and a second year as a McLaughlin Fellow, training in Head and Neck Oncology at the Royal Marsden Hospital in London, UK. He was the first fellow of the Advanced Training Council sponsored by the two head and neck societies.
A Full Professor, he occupies the Temmy Latner/Dynacare Chair in Head and Neck Oncology at the University of Toronto, Faculty of Medicine. He is Otolaryngologist-in-Chief at the Mount Sinai Hospital. He has an active practice focusing on head and neck oncology with a primary interest in endocrine surgery of the head and neck.
He has given over 500 scholarly presentations, has been invited as a visiting professor and surgeon internationally, and has published over 250 articles in the scientific literature. He has been involved in a number of administrative roles in the American Head and Neck Society and is also on the editorial board of a number of high impact journals focusing on head and neck oncology.
He has spare time to spend exercising, playing basketball, fly-fishing, traveling, collecting oriental rugs and vintage militaria, studying history and watching old movies. He is married to Elayne Bonnie Freeman, a graphic designer, and is the proud father of Lauren, Professor of Philosophy at the University of Louisville, Louisville, Kentucky and Allison, a fine arts graduate from Yale University and living in New York City.
Bryan Haugen, MD
Since finishing training at the University of Colorado Health Sciences Center in 1993, Dr. Haugen has been interested in the molecular mechanisms governing thyrotrope function and thyroid neoplasms.
His current clinical interests include thyroid neoplasms, advanced thyroid cancer, thyroid dysfunction and other endocrine tumors (parathyroid, adrenal, carcinoid). Dr Haugen’s research interests include molecular studies of thyroid neoplasm diagnosis and pathophysiology as well as the study of molecular therapeutic targets.
Specific areas of research include nuclear hormone receptors (RXR, TR, PPAR) and kinase signaling pathways as therapeutic targets in thyroid cancer, as well as proteomic approaches to molecular markers in thyroid neoplasms. His research group is also actively studying novel regulation of the hypothalamic-pituitary-thyroid axis.
Jatin P. Shah, MD
Jatin P. Shah, M.D. is Professor of Surgery at Cornell University, Chief of the Head and Neck Service, and holds The Elliott W. Strong Chair in Head and Neck Oncology at MSKCC. He graduated from MS University in Baroda, India, and trained in surgical oncology and head and neck surgery at MSKCC.
In addition to his patient care activities, Dr. Shah is an international leader in the field of head and neck surgery. He has delivered over 1,000 scientific presentations worldwide, published more than 400 peer reviewed articles and 8 medical textbooks. He has served as president of The New York Cancer Society, The New York Head and Neck Society, The Society of Head and Neck Surgeons, The North American Skull Base Society and the International Academy of Oral Oncology.
He founded The International Federation of Head and Neck Oncologic Societies (IFHNOS), and serves as its CEO. In recognition of his longstanding efforts to enhance patient care and physician training in head and neck surgery, Dr. Shah has received numerous awards, including an IFHNOS lecture, an American Head and Neck Society academic symposium, and an MSKCC academic chair named in his honor. He was awarded honorary fellowships from The Royal College of Surgeons of Edinburgh, London and Australia and honorary Ph.D. degrees from Belgium and Greece, the Blokhin Gold Medal from Russia and the Ellis Island Medal of Honor from the US. He was recently named the Most Distinguished Physician for 2011 in the USA by the American Association of Physicians from India.
Ashok R. Shaha, MD
Dr. Shaha is an Attending Surgeon on the Head and Neck Service at Memorial Sloan-Kettering Cancer Center, Jatin P. Shah Chair in Head and Neck Surgery, and Professor of Surgery at Cornell University Medical College, New York. Dr. Shaha completed his surgical training at M.S. University of Baroda, India and worked as a House Surgeon at Tata Memorial Hospital, where he developed an interest in head and neck surgical oncology.
After his arrival at Memorial Sloan-Kettering Cancer Center in 1975, Dr. Shaha did a surgical oncology fellowship and subsequently completed his surgical training at Downstate Medical Center in Brooklyn, New York. Dr. Shaha returned to Memorial Hospital in 1981 as a Fellow in Head and Neck Surgery.
He joined the Department of Surgery at Downstate Medical Center in 1982 as a Head and Neck Surgeon, rising to the rank of Professor of Surgery in 1992. During this period, he was also Chief of Head and Neck Surgery at King’s County, Brooklyn VA Hospital and University Hospital. From 1987 to 1989, Dr. Shaha spent two years as Acting Chief of Surgery at Brooklyn VA Medical Center. In August of 1993, Dr. Shaha moved to Memorial Sloan-Kettering Cancer Center as an Attending Surgeon on the Head and Neck Service.
During his post-graduate training, Dr. Shaha secured several gold medals and was given the Golden Apple Teaching Award at Downstate Medical Center. Other awards Dr. Shaha received include: Faculty Member of the AOA Honor Medical Society, the Outstanding Teacher Award at Memorial Sloan-Kettering Cancer Center in 1996, the Honor Award from the American Academy of Otolaryngology/Head and Neck Surgery, and he was named Visiting Professor of the Society of Head and Neck Surgeons in 1997 and 1998.
He has been honored by visiting professorships at University of Santa Tomas, Manila, and Sun Yat-Sen University Guang Zhou, China. Dr. Shaha has been actively involved in local and national head and neck societies, as well as having been President of the New York Head and Neck Society, the American Society for Surgeons of Indian Origin, and the Brooklyn Surgical Society. He was Co-President of the American Head and Neck Society, 1998-1999, and was President of the New York Cancer Society, 1999-2000 and President of the New York Surgical Society, 2004-2005. He is a member of many scientific organizations and serves on the editorial board of the Journal of Surgical Oncology, Head and Neck, Annals of Surgical Oncology, Brazilian Journal of Surgery, and Journal of Clinical Oncology.
He is an honorary member of the Brazilian College of Surgeons, the Cuban Surgical Society, Association of Surgeons of India, the Korean Head and Neck Society, Latin Head and Neck Society, Panamanian Society of Oncology, Chilean College of Surgeons, and Costa Rican Endocrine Society. He has been a visiting professor at many universities throughout the United States, as well as a guest speaker in many South American, Asian and European countries. He was the Program Chairman for the Fifth International Head and Neck Oncology Meeting in San Francisco (2000) and served as the Conference Chairman for the Sixth International Head and Neck Meeting in 2004. Recently Dr. Shaha was the recipient of the Distinguished Service Award by the American Academy of Otolaryngology – Head and Neck Surgery; he was recently nominated as President of the American Association of Endocrine Surgeons. Recently he was elected to the American Surgical Association.
Dr. Shaha has been academically active at national and international meetings, with approximately 585 papers, 435 of which are peer-reviewed (PubMed and Scopus). His Curriculum Vitae includes 140 published abstracts, 63 posters and 45 scientific exhibits presented. His research interests include tracheal reconstruction and an experimental model of tracheomalacia and thyroid cancer.
Dr. Shaha has dedicated his professional career to the training of medical students and residents and has developed a preceptorship program at Cornell University Medical College in head and neck training for medical students. He is Chairman of the Advanced Training Council for Head and Neck Oncology Fellowships in the USA.
Steven I. Sherman, MD
Steven I. Sherman is Naguib Samaan Distinguished Professor and Chair of the Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, at The University of Texas MD Anderson Cancer Center.
He received his medical degree from The Johns Hopkins School of Medicine, in Baltimore, Maryland, where he also completed his internship and residency in internal medicine and his fellowship in endocrinology and metabolism. Dr. Sherman holds board certifications in internal medicine and endocrinology, diabetes, and metabolism.
He is the director of the National Thyroid Cancer Treatment Cooperative Study Group, member of the Thyroid Cancer Panel of the National Comprehensive Cancer Network Guidelines Program, and Chairman of the International Thyroid Oncology Group. Dr. Sherman’s current and past research has focused on the management of patients with differentiated and medullary thyroid carcinomas.
He has emphasized two broad categories of research: what are the optimal uses of therapy and diagnostic monitoring for patients with low risk differentiated thyroid carcinomas, and what novel therapies can be used for patients with advanced thyroid carcinomas that are not responsive to more typical interventions. Dr. Sherman is author or co-author on more than 100 peer reviewed publications.
Ian Witterick, MD
Ian Witterick MD, MSc is Professor and Chair, Department of Otolaryngology-Head & Neck Surgery at the University of Toronto and Chief of Otolaryngology-Head & Neck Surgery, Mount Sinai Hospital, Toronto. He completed medical school at the University of Western Ontario followed by residency in Toronto and additional fellowships in head & neck oncology and rhinology.
He completed a Master’s degree in Clinical Epidemiology from the University of Toronto. He joined the staff of Mount Sinai Hospital, Toronto in 1993 and is a member of the Department of Surgical Oncology at Princess Margaret Cancer Centre. He is Chair of the Education Committee for the Faculty of Medicine at U of T and will finish his last year as Chair of the Examination Board in Otolaryngology-HNS for the RCPSC in 2012.
His clinical interests include head and neck oncology, rhinology and skull base surgery. He has expertise in education training and evaluation.